Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality

Role of GDF-15, YKL-40 and MMP 9 in patients with end-stage kidney disease: focus on sex-specific associations with vascular outcomes and all-cause mortality

Abstract Background Sex differences are underappreciated in the current understanding of cardiovascular disease (CVD) in association with chronic kidney disease (CKD). A hallmark of CKD is vascular aging that is characterised, amongst others, by; systemic inflammation, microbiota disbalance, oxidati...

Full description

Bibliographic Details
Main Authors: Agne Laucyte-Cibulskiene, Liam J. Ward, Thomas Ebert, Giulia Tosti, Claudia Tucci, Leah Hernandez, Alexandra Kautzky-Willer, Maria-Trinidad Herrero, Colleen M. Norris, Louise Pilote, Magnus Söderberg, Torkel B. Brismar, Jonaz Ripsweden, Peter Stenvinkel, Valeria Raparelli, Karolina Kublickiene, The GOING-FWD Consortium
Format: Article
Language:English
Published: BMC 2021-09-01
Series:Biology of Sex Differences
Subjects:
Biomarkers
Calcification
Cardiovascular disease
Chronic kidney disease
End stage kidney disease
TMAO
Online Access:https://doi.org/10.1186/s13293-021-00393-0

Internet

https://doi.org/10.1186/s13293-021-00393-0

Similar Items